Notice of Intent to Sole Source-MPF-ZAI SOLUTIONS

The Food and Drug Administration (FDA), specifically the Office of Acquisition and Grant Services under the Department of Health and Human Services, published a Notice of Intent to Sole Source on April 9, 2026. The notice announces the FDA's intention to award a Firm-Fixed-Price Purchase Order to MPF-ZAI SOLUTIONS LLC without competition. The agency has determined that MPF-ZAI SOLUTIONS LLC is the only known responsible source capable of meeting the government's requirements for the proposed work. This sole source determination is being made in accordance with FAR Part 6.302-1, which permits noncompetitive procurement when only one source can meet the agency's needs. The notice is categorized under NAICS 541990 (All Other Professional, Scientific, and Technical Services) and PSC R499 (Support-Professional: Other).

The FDA intends to contract with MPF-ZAI SOLUTIONS LLC for Center for Biologics Evaluation and Research (CBER) Scientific Data Abstraction and Information Management services. The agency has justified the sole source award by noting that MPF-ZAI SOLUTIONS possesses exclusive access to proprietary database systems and specialized methodologies, along with years of validated experience and technical expertise that no other vendor can match. Although the notice states this is not a request for competitive quotes, any responsible offeror may submit a proposal by the April 18, 2026 deadline to demonstrate their capability to provide the required services. Interested contractors must send submissions via email to Natalie.Brown@fda.hhs.gov and fully identify their technical capability and interest in performing the work. The government retains sole discretion to determine whether to proceed with the sole source award or open the competition based on responses received.